Genetic strategies to silence MyoD can restore susceptibility to apoptosis in IPF myofibroblasts, reinstate their ability to dedifferentiate, and partially reverse age-related persistent fibrosis in vivo [118]. This evidence concerns the gene MYOD1 and idiopathic pulmonary fibrosis.